Blog | bioMérieux

Living diagnostics

The blog that connects you with the in vitro diagnostic world.

April 24, 2024

Rapid Diagnostics & Antimicrobial Stewardship Can Guide Treatment for Sepsis Patients: Interview with Dr. Eric R. Wenzler

As pathogens change over time, they can become resistant to antibiotics, making it more difficult to treat infections that may lead to sepsis. This ongoing growth of antimicrobial-resistant bacteria continues to pose a threat to public health. We sat down for a virtual interview with Eric R. Wenzler, PharmD, BCPS, BCIDP, AAHIVP, Assistant Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago College of Pharmacy, to learn more about the role of diagnostics and stewardship intervention when caring for sepsis patients.

Sepsis

Latest articles

Swipe for more articles

April 10, 2024

How Pharmacists Can Contribute to Antimicrobial Stewardship?

We asked Dr. Catherine Duggan, CEO of the International Pharmaceutical Federation, about what clinical pharmacists can do in their roles to contribute to and promote antimicrobial stewardship.

Read more
March 26, 2024

Precision matters: Navigating the landscape of quality control in biologics

Humans have been using plant and animal derived products (biologics) to treat disease for thousands of years, but the advent of mass production in the 20th century enabled the growth of biologics as a recognized class of medicines. Unlike chemically derived medicines, which combine specific ingredients in an ordered process, biologics are typically very large, complex molecules or mixtures of molecules that are difficult to characterize.

Read more
March 21, 2024

Tuberculosis Management Four Years After COVID-19 Crisis

Tuberculosis (TB) fatalities continue to rise. In 2022, an estimated 10.6 million people fell ill with TB, compared to 10.3 million in 2021 and 10 million in 2020. The infectious disease killed 1.3 million people worldwide each year. In 2022, TB remained the second leading cause of death from an infectious disease, after COVID-19, and caused almost twice as many deaths as HIV/AIDS.

Read more
- Infectious Diseases
March 13, 2024

Antimicrobial Resistance Makes It Harder to Treat Urinary Tract Infections and Increases Risk of Sepsis and AKI

Antimicrobial resistant bacteria pose a major public health threat because they limit treatment options for infectious diseases. Common ailments like urinary tract infections (UTIs), which have often been easily and quickly cured by antibiotics historically, are becoming harder to treat due to resistant bacteria. Not only does this prolong discomfort for those suffering from UTIs, it also presents the danger that the infection may lead to a more serious condition.

Read more